, India
188 views
/Freepik

Life Insurance Corporation of India sees profits up 3.5% YoY in H1 2024

LIC's total premium income rose by 13.56% YoY.

Life Insurance Corporation of India (LIC) has reported a 3.51% increase in profit after tax (PAT) for the half-year ended 30 September, at ₹18,082 crore. 

The insurer maintained its lead in the Indian life insurance market with a total market share of 61.07%, up from 58.50% in the previous year.  

LIC's total premium income rose by 13.56% to ₹2,33,671 crore for the period, compared to ₹2,05,760 crore for the same period in 2023. 

Individual new business premium income grew 17.29% to ₹29,538 crore, while individual renewal premium income increased 5.07% to ₹1,15,158 crore. 

Group business premium income surged 25.36% to ₹88,975 crore.  

The insurer sold 91.7 lakh individual policies during the reporting period, a 13.77% increase from the 80.6 lakh policies sold in the same period last year. 

On an annualised premium equivalent (APE) basis, total premium stood at ₹28,025 crore, with 64.81% attributed to individual business and 35.19% to group business.  

The value of new business (VNB) increased by 37.74% to ₹4,551 crore, and the Net VNB margin improved to 16.2%, up 160 basis points from the previous year's 14.6%.  
 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.